Francy L Crosby

Title: Francy L. Crosby: Innovator in Vaccination Technology

Introduction

Francy L. Crosby is a notable inventor based in Ocala, Florida, recognized for her contributions to the field of vaccination technology. With a focus on immunization against gram-negative bacteria, she has made significant strides in developing innovative solutions that can benefit both animals and humans. Her work has led to the issuance of two patents, showcasing her expertise and dedication to advancing medical science.

Latest Patents

Crosby's latest patents revolve around the use of VirB10 for vaccination against infections caused by bacteria possessing Type IV Secretion Systems (T4SS). The invention details a vaccine that includes VirB10, a fragment of VirB10, or a polynucleotide encoding VirB10, along with a pharmaceutically acceptable carrier and/or adjuvant. This vaccine aims to immunize hosts against infections from T4SS bacteria, which can affect a wide range of species, including dogs, rabbits, cats, pigs, cattle, sheep, goats, deer, horses, rodents, and humans. The method of immunization involves administering the vaccine to the host, providing a comprehensive approach to combating these infections.

Career Highlights

Crosby is affiliated with the University of Florida Research Foundation Inc., where she continues to engage in groundbreaking research. Her work not only contributes to the scientific community but also has practical applications in veterinary and human medicine. The impact of her inventions is significant, as they address critical health challenges posed by bacterial infections.

Collaborations

Crosby has collaborated with esteemed colleagues, including Anthony F. Barbet, to further her research and development efforts. These partnerships enhance the quality and reach of her work, fostering an environment of innovation and shared knowledge.

Conclusion

Francy L. Crosby stands out as a pioneering inventor in the field of vaccination technology. Her contributions, particularly in the development of vaccines against gram-negative bacteria, highlight her commitment to improving health outcomes for various species. Through her work at the University of Florida Research Foundation Inc., she continues to make a lasting impact on the field of immunization.